Tuesday - March 24, 2026

Category Archives: Pharmaceuticals & Biotech

Epidermolysis Bullosa Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | RegeneRx Biopharma, BridgeBio Pharma, Berg Pharma, Holostem Terapie

Epidermolysis Bullosa pipeline constitutes 20+ key companies continuously working towards developing 21+ Epidermolysis Bullosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   “Epidermolysis Bullosa Pipeline Insight, 2026″ report by DelveInsight … Continue reading →

EGFR Non Small Cell Lung Cancer Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Bridge Biotherapeutics, Sichuan Kelun Pharms, BeBetter Med, Avistone Biotech

“EGFR Non Small Cell Lung Cancer Pipeline Insight, 2026″ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the EGFR Non Small Cell Lung Cancer Market.   The EGFR Non Small Cell Lung … Continue reading →

Cutaneous Lupus Erythematosus Market: Accelerating Growth and Pipeline Impact by 2034 – DelveInsight | Biogen, Horizon Therapeutics, Bristol–Myers Squibb, AstraZeneca, Sanofi, Amgen, Gilead Sciences

The Key Cutaneous Lupus Erythematosus Companies in the market include – Biogen, Horizon Therapeutics, Bristol–Myers Squibb, AstraZeneca, Sanofi, Amgen, Biogen, Gilead Sciences, Pfizer, Bristol-Myers Squibb, Novartis, Rigel Pharmaceuticals, Merck, and others.   DelveInsight’s “Cutaneous Lupus Erythematosus Market Insights, Epidemiology, and … Continue reading →

Projecting the Global Sinus Dilation Devices Market Size to Expand at a 9.38% CAGR Through 2032, DelveInsight Analysis

“Sinus Dilation Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The sinus dilation devices market is largely … Continue reading →

Hypersomnia Pipeline Advances with 3+ Companies Developing Innovative Therapies and Expanding Clinical Research | DelveInsight

Hypersomnia Pipeline Key Hypersomnia companies involved in drug development include Axsome Therapeutics, Alkermes, Zevra Therapeutics, Takeda, and Aexon Labs, among others. Hypersomnia Pipeline Advances with 3+ Companies Developing Innovative Therapies and Expanding Clinical Research | DelveInsight Key Hypersomnia companies involved … Continue reading →